Answers are grounded in this paper and cite their sources.
Introduction: To evaluate and compare the benefits of multiparametric magnetic resonance imaging (mpMRI) in combination with fusion prostate biopsy (fPBx) and find out what happened with patients underwent single MRI without fPBx.Materials and methods: 125 patients underwent prostate mpMRI.Sixty-five of these patients additionally underwent ultrasound-guided fPBx.Prostate lesions were scored using the Prostate Imaging Reporting and Data System version 2, and the results were verified with prostate biopsies.Results: Sixty-five patients (52%) underwent fPBx after mpMRI, and 60 patients (48%) underwent mpMRI alone as ordered by their physician.Of the 65 men who underwent fPBx, PCa was verified in 33 men (50.77%) who exhibited suspicious lesions on mpMRI, whereas 20 men (30.77%) yielded negative results, although suspicious lesions were observed by mpMRI.Among the 65 men, 7 (10.76%)and 5 (7.7%) men had atypical small acinar proliferation and chronic prostatitis, respectively.The mean PCa detection rate for standard biopsy was 21.9% (SD, 26.4), whereas that of the mpMRI combined with fPBx was 49.5% (SD, 41.9) (p-value <0.0001).Of the 53 patients who underwent biopsy, 13 patients underwent the algorithm mpMRI/fPBx for first-line diagnosis, with nearly 70% patients (n=9) experiencing positive results.Conclusion: fPBx detected considerably more cases of PCa than standard biopsies, demonstrating the clear advantages of the former method.Because of the wellknown low specificity of mpMRI, this method alone is insufficient for the diagnosis of PCa if no further diagnostic interventions are planned.
No takes yet. Share an insight, caveat, or question.
Lunacek et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: